Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06605534 · ClinicalTrials.gov registry record · NA
Leveraging the Emergency Department (LEAD) Study
A NA study of Lung Cancer, sponsored by Hackensack Meridian Health.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 10
- Study locations
NCT06605534: Recruiting NA study of Lung Cancer, sponsored by Hackensack Meridian Health.
NCT06605534 is a NA study of Lung Cancer that is actively recruiting participants, run by Hackensack Meridian Health. The registered enrollment target is 100 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (89% lower). The trial reports 10 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06605534, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Hackensack Meridian Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 10
- Study locations
Study Summary
This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial. The study will first examine reach in a non-traditional setting (the Emergency Department - ED) that uses an Electronic Health Record (EHR)-embedded Social Determinants of Health (SDoH) screening tool to identify lung screening-eligible patients for a tailored intervention to increase lung screening uptake. Reach is defined as the absolute number, proportion, and representativeness of individuals targeted for lung screening knowledge, awareness, and uptake. Then, a pilot trial will be conducted to examine the preliminary effectiveness of a tailored lung screening intervention compared to enhanced usual care to influence individual-level potential drivers of lung screening (health literacy, mistrust, stigma, fatalism, knowledge, lung screening health beliefs) and the ability to increase lung screening uptake among screening-eligible patients. Quantitative (Randomized Controlled Trial and EHR data) methods will be used for data collection and analysis to address the study aims.
Primary Outcome
Completion of a Screening Low-Dose Computed Tomography (LDCT) of the Chest confirmed via Electronic Health Records (EHR))
Conditions Studied
Interventions
- BEHAVIORAL LungTalk
- OTHER Non-tailored lung screening
Study Locations (10)
New Jersey
- Ocean Medical Center - Brick
- John F. Kennedy Medical Center - Edison
- Hackensack University Medical Center - Hackensack
- Bayshore Medical Center - Holmdel
- Southern Ocean Medical Center - Manahawkin
- Jersey Shore University Medical Center - Neptune City
- Palisades Medical Center - North Bergen
- Old Bridge Medical Center - Old Bridge
- Raritan Bay Medical Center - Perth Amboy
- Riverview Medical Center - Red Bank
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-10-29 |
| Est. Completion | 2026-10-30 |
| Phase | NA |
What NCT06605534 shows while recruiting
NCT06605534 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which LungTalk is the first listed.
NCT06605534 lists 10 locations in 1 state (New Jersey).
Frequently Asked Questions
What is clinical trial NCT06605534 about?
NCT06605534 is a clinical study titled "Leveraging the Emergency Department (LEAD) Study". This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial. The study will first examine reach in a non-traditional setting (the Emergency Department - ED) that uses an Electronic Health Record (EHR)-embedded Social Determinants of Health (SDoH) screening tool to identify lung screening-eligib...
What is the current status of trial NCT06605534?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-10-29. Estimated completion is 2026-10-30.
What conditions does trial NCT06605534 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT06605534?
The interventions under investigation include: LungTalk (BEHAVIORAL), Non-tailored lung screening (OTHER).
Who is sponsoring clinical trial NCT06605534?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06605534 being conducted?
This trial has 10 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06605534's enrollment target sits among peer trials
100 186th of 409 higher than 212 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI